Kinnari Patel - 17 May 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
President & Chief Operating Officer
Signature
/s/ Martin Wilson, as attorney-in-fact for Kinnari Patel
Issuer symbol
RCKT
Transactions as of
17 May 2023
Net transactions value
-$28,429
Form type
4
Filing time
19 May 2023, 16:05:32 UTC
Previous filing
16 May 2023
Next filing
15 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale $28,429 -1,330 -0.62% $21.38 213,993 17 May 2023 Direct F1
holding RCKT Common Stock 5,675 17 May 2023 By Spouse
holding RCKT Common Stock 98,261 17 May 2023 By Adaptive Technology LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.
F2 The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband.

Remarks:

President & Chief Operating Officer